Calpains as potential anti-cancer targets

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 3, 2011, Pages 309-323

  Leloup, Ludovic ^a   Wells, Alan ^b  

^a University of the Mediterranean Aix Marseille II   (France)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Calpains; Cancer; Invasion; Migration

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; BORTEZOMIB; CALPAIN; CALPAIN 3; CALPAIN 6; CALPAIN 9; CALPASTATIN; CISPLATIN; CURCUMIN; GENISTEIN; OXALIPLATIN; RANIBIZUMAB; RESVERATROL; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CLINICAL TRIAL; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; METASTASIS; MYELOMA; NONHUMAN; PRIMARY TUMOR; PROTEIN FUNCTION; REVIEW; TUMOR VASCULARIZATION;

EID: 79951600584     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2011.553611     Document Type: Review

References (101)

1. Goll DE, Thompson VF, Li H, e (Pubitemid 36828925)
2. Schad E, Farkas A, Jekely G, et al. A novel human small subunit of calpains. Biochem J 2002;362:383-8 (Pubitemid 34214480)
3. Kulkarni S, Goll DE, Fox JEB. Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J Biol Chem 2002;277:24435-41 (Pubitemid 34951967)
4. Huang C, Rajfur Z, Yousefi N, et al. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol 2009;11:624-30
5. Gregoriou M, Willis AC, Pearson MA, et al. The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Eur J Biochem 1994;223:455-64 (Pubitemid 24244192)
6. Franco SJ, Rodgers MA, Perrin BJ, et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 2004;6:977-83 (Pubitemid 39359850)
7. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-75
8. Saito K, Elce JS, Hamos JE, et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993;90:2628-32 (Pubitemid 23113469)
9. Mellgren RL. Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase. Biochem Biophys Res Commun 1997;236:555-8 (Pubitemid 27384663)
10. Janossy J, Ubezio P, Apati A, et al. Calpain as a multi-site regulator of cell cycle. Biochem Pharmacol 2004;67:1513-21 (Pubitemid 38388213)
11. Joy J, Nalabothula N, Ghosh M, et al. Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d). Biol Chem 2006;387:329-35
12. Choi YH, Lee SJ, Nguyen P, et al. Regulation of cyclin D1 by calpain protease. J Biol Chem 1997;272:28479-84 (Pubitemid 27517796)
13. Wang XD, Rosales JL, Magliocco A, et al. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 2003;22:769-74 (Pubitemid 36269291)
14. Chen Z, Knutson E, Kurosky A, et al. Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol 2001;75:3613-25 (Pubitemid 32246371)
15. Delmas C, Aragou N, Poussard S, et al. MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J Biol Chem 2003;278:12443-51 (Pubitemid 36800231)
16. Smith PD, Mount MP, Shree R, et al. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 2006;26:440-7 (Pubitemid 43237108)
17. Squier MK, Miller AC, Malkinson AM, et al. Calpain activation in apoptosis. J Cell Physiol 1994;159:229-37 (Pubitemid 24141929)
18. Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 2000;275:5131-5 (Pubitemid 30108915)
19. Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000;150:887-94 (Pubitemid 30663424)
20. Wang KK. Calpain and caspase: can you tell the difference? Trends Neurosci 2000;23:20-6 (Pubitemid 30100309)
21. Kubbutat MH, Vousden KH. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 1997;17:460-8 (Pubitemid 26425636)
22. Glading A, Lauffenburger DA, Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002;12:46-54 (Pubitemid 34164156)
23. Bhatt A, Kaverina I, Otey C, et al. Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J Cell Sci 2002;115:3415-25 (Pubitemid 34994031)
24. Sheetz MP, Felsenfeld D, Galbraith CG, et al. Cell migration as a five-step cycle. Biochem Soc Symp 1999;65:233-43 (Pubitemid 129541623)
25. Shao H, Chou J, Baty CJ, et al. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol 2006;26:5481-96 (Pubitemid 44036214)
26. Leloup L, Shao H, Bae YH, et al. m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2010;285:33549-66
27. Franco S, Perrin B, Huttenlocher A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp Cell Res 2004;299:179-87 (Pubitemid 39078393)
28. Mamoune A, Luo J, Lauffenburger DA, et al. Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res 2003;63:4632-40 (Pubitemid 36951041)
29. Cortesio CL, Chan KT, Perrin BJ, et al. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol 2008;180:957-71 (Pubitemid 351398422)
30. Popp O, Heidinger M, Ruiz-Heinrich L, et al. The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells. Biol Chem 2003;384:951-8 (Pubitemid 36874510)
31. Carragher NO, Frame MC. Calpain: a role in cell transformation and migration. Int J Biochem Cell Biol 2002;34:1539-43
32. Carragher NO, Westhoff MA, Riley D, et al. v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation. Mol Cell Biol 2002;22:257-69 (Pubitemid 33144273)
33. Carragher NO, Fonseca BD, Frame MC. Calpain activity is generally elevatedduring transformation but has oncogene-specific biological functions. Neoplasia 2004;6:53-73 (Pubitemid 38391949)
34. Niapour M, Yu Y, Berger SA. Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression. J Biol Chem 2008;283:21371-81
35. Ciuffini L, Castellani L, Salvati E, et al. Delineating v-Src downstream effector pathways in transformed myoblasts. Oncogene 2008;27:528-39
36. Small GW, Chou T, Dang CV, et al. Evidence for involvement of calpain in c-Myc proteolysis in vivo. Arch Biochem Biophys 2002;400:151-61 (Pubitemid 34852395)
37. Sergeev IN. Genistein induces Ca2+-mediated, calpain/caspase-12- dependent apoptosis in breast cancer cells. Biochem Biophys Res Commun 2004;321:462-7 (Pubitemid 39055768)
38. Martinez JA, Zhang Z, Svetlov SI, et al. Calpain and caspase processing of caspase-12 contribute to the ER stress-induced cell death pathway in differentiated PC12 cells. Apoptosis 2010;15:1480-93
39. Tan Y, Dourdin N, Wu C, et al. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 2006;281:16016-24 (Pubitemid 43848495)
40. Shim H, Park J, Paik H, et al. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Anticancer Drugs 2007;18:649-57 (Pubitemid 47343657)
41. Yeh T, Chiang P, Li T, et al. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol 2007;73:782-92 (Pubitemid 46227339)
42. Das A, Banik NL, Ray SK. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer 2010;116:164-76
43. Sareen D, Darjatmoko SR, Albert DM, et al. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 2007;72:1466-75 (Pubitemid 350146084)
44. Xie S, Zhang Z, Hu G, et al. HL-37, a novel anthracene derivative, induces Ca2+-mediated apoptosis in human breast cancer cells. Toxicology 2008;254:68-74
45. Liu L, Xing D, Chen WR, et al. Calpain-mediated pathway dominates cisplatin-induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis. Int J Cancer 2008;122:2210-22 (Pubitemid 351542323)
46. Liu L, Xing D, Chen WR. Micro-calpain regulates caspase-dependent and apoptosis inducing factor-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis. Int J Cancer 2009;125:2757-66
47. Anguissola S, Kohler B, O'Byrne R, et al. Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cells. Mol Pharmacol 2009;76:998-1010
48. Wu Z, Chao CC. Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: implications to overcome chemoresistance. Biochem Pharmacol 2010;80:827-37
49. Lee SK, Park MS, Nam MJ. Aspirin has antitumor effects via expression of calpain gene in cervical cancer cells. J Oncol 2008;2008:285374
50. Karmakar S, Banik NL, Patel SJ, et al. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci Lett 2006;407:53-8 (Pubitemid 44345016)
51. Karmakar S, Banik NL, Ray SK. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res 2007;32:2103-13 (Pubitemid 350059854)
52. Kulkarni S, Reddy KB, Esteva FJ, et al. Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer. Oncogene 2010;29:1339-50
53. Li C, Chen S, Yue P, et al. Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaBalpha degradation. J Biol Chem 2010;285:16096-104
54. Wells A, Kassis J, Solava J, et al. Growth factor-induced cell motility in tumor invasion. Acta Oncol 2002;41:124-30 (Pubitemid 34557071)
55. Kassis J, Radinsky R, Wells A. Motility is rate-limiting for invasion of bladder carcinoma cell lines. Int J Biochem Cell Biol 2002;34:762-75 (Pubitemid 34304166)
56. Huttenlocher A, Ginsberg MH, Horwitz AF. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 1996;134:1551-62 (Pubitemid 26318026)
57. Dourdin N, Bhatt AK, Dutt P, et al. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 2001;276:48382-8
58. Bodnar RJ, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 2006;98:617-25
59. Su Y, Cui Z, Li Z, et al. Calpain-2 regulation of VEGF-mediated angiogenesis. FASEB J 2006;20:1443-51 (Pubitemid 44943852)
60. Satish L, Blair HC, Glading A, et al. Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol Cell Biol 2005;25:1922-41 (Pubitemid 40280155)
61. Dedieu S, Poussard S, Mazeres G, et al. Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp Cell Res 2004;292:187-200 (Pubitemid 38058275)
62. Leloup L, Mazeres G, Daury L, et al. Involvement of calpains in growth factor-mediated migration. Int J Biochem Cell Biol 2006;38:2049-63 (Pubitemid 44397612)
63. Glading A, Chang P, Lauffenburger DA, et al. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 2000;275:2390-8 (Pubitemid 30081997)
64. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001;37(Suppl 4):S9-15 (Pubitemid 32938124)
65. Xu L, Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone induces phosphorylation of μ- and m-calpain in association with increased secretion, cell migration, and invasion. J Biol Chem 2004;279:53683-90 (Pubitemid 40051876)
66. Xu L, Deng X. Protein kinase Ci promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of mu- and m-calpains. J Biol Chem 2006;281:4457-66 (Pubitemid 43847877)
67. Meng XN, Jin Y, Yu Y, et al. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 2009;101:327-34
68. Roumes H, Leloup L, Dargelos E, et al. Calpains: markers of tumor aggressiveness? Exp Cell Res 2010;316:1587-99
69. Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907:191-217 (Pubitemid 18005336)
70. Fan D, Dai J, Tang J, et al. Silencing of calpain expression reduces the metastatic potential of human osteosarcoma cells. Cell Biol Int 2009;33:1263-7
71. Brustis JJ, Elamrani N, Balcerzak D, et al. Rat myoblast fusion requires exteriorized m-calpain activity. Eur J Cell Biol 1994;64:320-7 (Pubitemid 24258191)
72. Xu L, Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J Biol Chem 2006;281:35567-75 (Pubitemid 46036590)
73. Carragher NO, Walker SM, Scott Carragher LA, et al. Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene 2006;25:5726-40 (Pubitemid 44435250)
74. Martiny-Baron G, Marme D. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr Opin Biotechnol 1995;6:675-80
75. Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997;1333:F179-99 (Pubitemid 28015313)
76. Allegra CJ, Yothers G, O'Connell MJ, et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 2011;29:11-16
77. Bodnar RJ, Yates CC, Rodgers ME, et al. IP-10 induces dissociation of newly formed blood vessels. J Cell Sci 2009;122:2064-77
78. Shiraha H, Glading A, Chou J, et al. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol 2002;22:2716-27 (Pubitemid 34262992)
79. Lasagni L, Francalanci M, Annunziato F, et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 2003;197:1537-49 (Pubitemid 36682550)
80. Ono Y, Shimada H, Sorimachi H, et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 1998;273:17073-8 (Pubitemid 28311741)
81. Moretti D, Del Bello B, Cosci E, et al. Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis 2009;30:960-7
82. Roperto S, De Tullio R, Raso C, et al. Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle. PLoS ONE 2010;5:e10299
83. Lee S, Kim B, Choi Y, et al. Increased expression of calpain 6 during the progression of uterine cervical neoplasia: immunohistochemical analysis. Oncol Rep 2008;19:859-63 (Pubitemid 351802652)
84. Rho SB, Byun H, Park S, et al. Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis. Cancer Lett 2008;271:306-13
85. Yoshikawa Y, Mukai H, Hino F, et al. Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 2000;91:459-63 (Pubitemid 30392314)
86. Liu K, Li L, Cohen SN. Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumorigenesis. J Biol Chem 2000;275:31093-8
87. Shiba E, Kambayashi JI, Sakon M, et al. Ca2+-dependent neutral protease (calpain) activity in breast cancer tissue and estrogen receptor status. Breast Cancer 1996;3:13-17
88. Lakshmikuttyamma A, Selvakumar P, Kanthan R, et al. Overexpression of m-calpain in human colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev 2004;13:1604-9 (Pubitemid 39331881)
89. Das A, Banik NL, Patel SJ, et al. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 2004;3:36
90. Rios-Doria J, Day KC, Kuefer R, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 2003;278:1372-9 (Pubitemid 36790823)
91. Reichrath J, Welter C, Mitschele T, et al. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. J Pathol 2003;199:509-16 (Pubitemid 36411228)
92. Braun C, Engel M, Seifert M, et al. Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int J Cancer 1999;84:6-9 (Pubitemid 29059100)
93. Daniel KG, Anderson JS, Zhong Q, et al. Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis. Int J Mol Med 2003;12:247-52
94. Bai D, Dai Z, Zhou J, et al. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology 2009;49:460-70
95. Kothapalli R, Bailey RD, Kusmartseva I, et al. Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 2003;22:33-9
96. Salehin D, Fromberg I, Haugk C, et al. Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer. Anticancer Res 2010;30:2837-43
97. Esteban F, Royo JL, Gonzalez-Moles MA, et al. CAPN10 alleles modify laryngeal cancer risk in the Spanish population. Eur J Surg Oncol 2008;34:94-9
98. Akashiba H, Matsuki N, Nishiyama N. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons. J Neurochem 2006;99:733-44 (Pubitemid 44583433)
99. Kaneko T, Yamashima T, Tohma Y, et al. Calpain-dependent proteolysis of merlin occurs by oxidative stress in meningiomas: a novel hypothesis of tumorigenesis. Cancer 2001;92:2662-72 (Pubitemid 33049451)
100. Averna M, Stifanese R, De Tullio R, et al. Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells. J Neurochem 2009;110:412-21
101. Chen C, Nguyen T, Shively JE. Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells. Exp Cell Res 2010;316:638-48